N-(3,4-Difluorophenyl)-2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}acetamide CAS 303091-73-8
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 303091-73-8 |
| Molecular Formula | C19H18F5N3O |
| Molecular Weight | 399.36 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
N-(3,4-Difluorophenyl)-2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}acetamide (CAS 303091-73-8) is a pharmaceutical standards certified reference material from CATO. Molecular formula: C19H18F5N3O. Molecular weight: 399.36 g/mol. ISO 17034 accredited production ensures traceable purity and reliable analytical results.
Physical & Chemical Properties
| Molecular Formula | C19H18F5N3O |
| Molecular Weight | 399.36 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2025 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 3 |
Related N Standards
- 1-(2,4-Difluorophenyl)-3-{1-[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]cyclohexyl}urea (CAS 1396876-68-8)
- N-[1-(2,4-Difluorophenyl)-4,5,6,7-tetrahydro-1H-indazol-4-yl]-4,5,6,7-tetrahydro-1,2-benzisoxazole-3-carboxamide (CAS 1069679-70-4)
- 2-(2,4-Difluorophenyl)-4-methyl-6-(2-phenylthiazol-4-yl)-1,2,4-triazine-3,5(2H,4H)-dione (CAS 477854-26-5)
- N-(2,4-difluorophenyl)-4-methyl-2-(3-(trifluoromethyl)phenyl)thiazole-5-carboxamide (CAS 320420-97-1)
- n-(2-((3,4-Difluorophenyl)amino)-2-oxoethyl)-3-(n-ethylsulfamoyl)benzamide (CAS 941377-20-4)
- (2,6-Difluorophenyl)(4-(6-(pyridin-4-ylamino)pyridazin-3-yl)piperazin-1-yl)methanone (CAS 1020978-57-7)
- 2-[(3,5-Difluorophenyl)methyl]-4-(5-ethyl-1,2,4-oxadiazol-3-yl)-1H,2H,3H,5H,6H,7H,8H,9H-pyrimido[1,6-a]azepine-1,3-dione (CAS 1775310-43-4)
- 2-[(3,4-Difluorophenyl)methyl]-4-(5-ethyl-1,2,4-oxadiazol-3-yl)-1H,2H,3H,5H,6H,7H,8H,9H-pyrimido[1,6-a]azepine-1,3-dione (CAS 1775346-12-7)
Recommended Standards
- 4,4'-((3,4-Dichlorophenyl)methylene)bis(N,N-dimethylaniline) (CAS 6310-47-0)
- Bicalutamide Impurity 36 (CAS CATO-C4X-101336)
- 2-Bromo-1-(3,4-dimethoxyphenyl)dodecan-1-one (CAS 63828-97-7)
- 4-(4-Hydroxytetrahydropyran-4-yl)phenylboronic acid (CAS 1622986-23-5)
- 1-(4-Bromobenzyl)piperidin-4-amine dihydrochloride (CAS 1286264-50-3)
- Ethyl 2-(2-chloro-4-fluoro-3-methylphenyl)acetate (CAS 1807036-85-6)
- 2-[2-(2-Bromo-4-chlorophenoxy)ethyl]piperidinehydrochloride (CAS 1219982-90-7)
- (6-Bromo-2,2-dimethylchroman-4-yl)methanamine (CAS 1783751-41-6)
- Cefpirome Sulfate (CAS 98753-19-6)
- Experimental Allergic Encephalitogenic Peptide (CAS 29705-92-8)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com